New approaches in the management of Chronic Obstructive Pulmonary Disease (COPD): The 2018 Update

Goodfellow Symposium
Saturday March 24, 2018

Presentation by:
Associate Professor Robert Young
Consultant Physician, Auckland Hospital

In this Breakfast Symposium, Associate Professor Rob Young addressed commonly
asked questions from primary care clinicians on the best approaches to managing COPD
patients in everyday practice.  He also presented the latest evidence on diagnosis,
management and prevention of COPD, in New Zealand and from an international perspective,
in this update.




To start viewing a specific topic, please click title below.

1. Overview of treatments available for COPD in New Zealand
2. The changing landscape of COPD; Update and summary of the 2017 and 2018 Global Obstructive Lung Disease (GOLD) strategy recommendations
3. GOLD 2017/2018 changes for management of stable COPD; FEV1 for diagnosis and prognosis
4. Distilling the GOLD strategy update; COPD in the New Zealand context
5. What are the benefits of dual bronchodilation?
6. Are there data that compares bronchodilator products?
7. Which of my COPD patient would benefit from Inhaled Corticosteroids/management of patients with a previous diagnosis of Asthma?
8. Non-pharmacological treatment for COPD
9. Take home messages
10. Questions from the audience
 


This presentation was sponsored by GSK

GSK NZ Limited
Private Bag 106600
Auckland